$RYET pushing through $0.90, up +2.67% with the Malaysia healthcare catalyst still fresh.
Holding strength after the BioNexus/Cogni AI news.
Watching for continuation if $0.90 keeps acting like support
The agreement includes an exclusive license framework of up to 20 years. The timing matters because healthcare AI adoption is accelerating globally. RYET is worth keeping on the radar.
$TWLO #bb28#BBNaija
BREAKING: $RYET just added a completely new business lane in Malaysia.
The company announced an agreement with BioNexus Gene Lab that brings Cogni AI into healthcare, moving the technology beyond education and enterprise use cases
clean structure, 10% royalty plus equity is the kind of skin-in-the-game deal u wanna see. licensing angle is the real unlock here
#teenageee
$TGT $LUNR
The agreement can run for up to 20 years, $RYET gets 10% royalty economics on qualifying technology receipts, and 560K $BGLC shares at closing
In simple terms: RYET is trying to turn Cogni AI into something that can be licensed, used in new industries and monetized outside its original business.
That’s the part of the news I find interesting
$RYET's volume hasn't cooled off and that revenue guide puts real numbers behind the move. $VEEA could be the clean continuation play here
#bb28
$XOM $F
Two names are lighting up the morning watchlist
$RYET stays on high alert after last week’s volume surge and the $9.3M-$9.5M H1 FY2027 revenue update
Meanwhile $VEEA is showing strong premarket momentum
Different setups, same theme: traders are watching for continuation
BREAKING: $RYET is expanding into Malaysian healthcare 🇲🇾
Ruanyun/Formind announced an exclusive Cogni AI licensing agreement with Nasdaq-listed BioNexus Gene Lab, opening a completely new healthcare vertical for the company.
Key terms:
• Exclusive Cogni AI license for up to 20 years
• 10% royalty on qualifying technology receipts
• 560,000 BGLC shares to RYET at closing
• Focus on AI-powered healthcare applications in Malaysia
BioNexus operates in genomic screening and precision healthcare, giving Cogni AI a potential path into real healthcare workflows
This comes as $RYET is already expanding beyond its original education business into AI platforms, Smart Campus services and international markets.
Education. Enterprise AI. Now healthcare
Malaysia is becoming a much bigger part of the Formind expansion story.
$9.3M-$9.5M in just 6 months
$RYET now expects preliminary H1 FY2027 revenue above the company’s entire FY2026 revenue of $7.48M.
A year earlier, the same half was only about $0.37M.
That’s a major change in scale
$SAIO $PCVX $VEEA $PTC $QTEX are on the radar today, but $RYET is the one I’m watching closest
RYET fresh revenue news changed the setup, and if volume builds, this small-cap could get very active
Catch the signal. Skip the noise.
Join a focused market community where traders discuss fresh news, unusual activity, catalysts and setups across stocks and tech
Research first. No guaranteed calls. No hype promises
Join the Discord community:https://t.co/nu9lamKT3d
$RYET H1 FY2027 prelim revenue $9.3M-$9.5M vs $0.37M a year earlier. Smart Campus alone $5.0M-$5.2M. Unaudited, but that jump is wild 🚀
#BBNaija
$WMT $CAT
I had to look twice at the new $RYET numbers
Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, versus only about $0.37M in H1 FY2026
That’s a huge change in scale in just one year
$RYET just guided H1 FY2027 to $9.3M-$9.5M vs ~$0.37M in H1 FY2026. That's a completely different company. Smart Campus alone contributing ~$5.0M-$5.2M 🔥
#nolimitt
$BA $AVGO
$RYET H1 FY2027 revenue is expected at $9.3M-$9.5M
That’s not just growth - it’s a major scale shift compared with ~$0.37M in H1 FY2026
If these preliminary numbers hold, the financial story looks very different now
The strongest part of the $RYET update isn’t the headline growth
It’s the mix
$5.0M-$5.2M expected from campus services
$2.4M-$2.5M from smart-campus infrastructure
$0.4M-$0.5M from AI applications
Multiple revenue engines are starting to show up at the same time
$RYET is starting to look like a name traders should have on radar
FY2026 revenue reached $7.48M, +11.9% YoY, while YeeZo secured an ~$880K deployment across 10 AIGC labs and 610 workstations
Add the new Formind strategy and rising attention around the stock, and there is a real catalyst story developing here
Worth watching the next company update closely
One number stands out on $RYET: ~$880K
That YeeZo deployment covers 10 AIGC labs + 610 workstations for a company with $7.48M FY2026 revenue
The next thing to watch is whether more deployments follow
$RYET is setting up at an interesting spot
Price around $0.82, market cap near $30.6M, with Formind still the latest catalyst
Chart is holding the lower range while RSI starts recovering, and a reclaim of the descending trendline could put $0.95-$1.00 back in focus first
Watching volume closely here
@modern_rock@MonacoTrader@lx21